Copyright
©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5463-5469
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5463
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5463
Table 1 Pathogen detection in two patients with visceral leishmaniasis
Etiological examination | Case 1 | Case 2 |
Epstein-Barr virus | 2.82 x 103 | Negative |
K39 tests | Positive | Positive |
Cytomegalovirus | Negative | Negative |
Rubella virus | Negative | Negative |
Influenza virus | Negative | Negative |
Respiratory syncytial virus | Negative | Negative |
Adenovirus | Negative | Negative |
Antihemolytic streptococcus O | Normal | Normal |
Rheumatoid factor | Normal | Normal |
Anti-cyclic citrullinated peptide antibody | Negative | Negative |
Anti-nuclear antibody | Negative | Negative |
Legionella pneumophila | Negative | Negative |
Mycoplasma pneumoniae, Chlamydia | Negative | Negative |
Q fever, rickettsia | Negative | Negative |
Blood culture | Negative | Negative |
Bone marrow cytology | ||
Leishmania amastigotes | Positive | Positive |
Hemophagocytic cells | Easily seen | Easily seen |
Hemophagocytic-related genes | Negative | Negative |
Acute and chronic leukemia immunophenotyping | Negative | Negative |
Table 2 Routine blood indices, infection indices, and biochemical results for both patients on admission and after hemophagocytic lymphohistiocytosis-2004 chemotherapy regimen treatment for 14 d and SSG treatment for 21 d
Detection index | Normal range | On admission | After HLH-2004 chemotherapy regimen treatment for 14 d | After SSG treatment for 21 d | |||
Characteristic | Case 1 | Case 2 | Case 1 | Case 2 | Case 1 | Case 2 | |
White blood cell count (× 109/L) | 4.0–10.0 | 2 | 4.5 | 3.4 | 3.9 | 4.6 | 5.8 |
Red blood cell count (× 1012/L) | 4.0–5.5 | 2 | 3.8 | 3.3 | 3.3 | 3.83 | 4.08 |
Hemoglobin (g/L) | 97-141 | 69 | 94 | 91 | 97 | 112 | 119 |
Platelet count (× 109/L) | 100–300 | 35 | 44 | 66 | 28 | 118 | 110 |
High-sensitivity C-reactive protein (mg/L) | 0.5-10.0 | 151.8 | 198.3 | 85.3 | 16.3 | 5.9 | 2.3 |
Procalcitonin (ng/mL) | 0-0.25 | 5.4 | 2.3 | 3.5 | 1.8 | 0.25 | 0.25 |
Ferritin (μg/L) | 7.0-142.0 | 40000 | 69445 | 1886 | 2000 | 128 | 116 |
Fibrinogen (g/L) | 2.0-4.0 | 1.2 | 0.9 | 1.1 | 1.4 | 2.6 | 3.3 |
Alanine aminotransferase (U/L) | 0-40.0 | 75 | 178 | 41 | 149 | 39 | 28 |
Total protein (g/L) | 55.0-76.0 | 62.2 | 55.7 | 62.2 | 65.1 | 64.2 | 66.1 |
Albumin (g/L) | 39.0-54.0 | 24.7 | 29.2 | 24.7 | 30.9 | 40.5 | 42.7 |
Globulin (g/L) | 12.0-34.0 | 37.5 | 36.5 | 37.5 | 34.2 | 23.7 | 23.4 |
Lactate dehydrogenase (U/L) | 109.0-245.0 | 2700 | 2648 | 256 | 1803.8 | 238 | 226 |
Triglycerides (mmol/L) | 1.70-2.30 | 4.2 | 4.5 | 2 | 2.5 | 2.1 | 1.9 |
- Citation: Shi SL, Zhao H, Zhou BJ, Ma MB, Li XJ, Xu J, Jiang HC. Diagnostic value of bone marrow cell morphology in visceral leishmaniasis-associated hemophagocytic syndrome: Two case reports. World J Clin Cases 2022; 10(16): 5463-5469
- URL: https://www.wjgnet.com/2307-8960/full/v10/i16/5463.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i16.5463